Delivery Order SPE2DB20D2014-SPE2DB24FB93A

Award Date 5/15/24
Potential Completion Date 5/16/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,682.46 firm-fixed-price delivery order is for the supply of 24,000 unit capsules of the drug CREON DR. The award is not associated with a set-aside and is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.70 firm fixed price delivery order is for the supply of 24,000 unit capsules of the medication Creon DR. The contract has an ultimate completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,299.23 Firm Fixed Price Delivery Order covers the supply of 36,000 unit capsules of the drug CREON DR 100S. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,212.12 Firm Fixed Price Delivery Order contract has an ultimate completion date of March 20, 2025. It covers the provision of 24,000 unit capsules of the drug CREON DR. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,565.36 firm fixed-price delivery order is for the supply of 36,000 unit capsules of CREON DR 100s, with a completion date of January 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $13,200.39 firm fixed price delivery order is for 36,000 units of the drug CREON DR 100S capsules. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,464.05 firm fixed-price delivery order contract is for the supply of 24,000 units of the pharmaceutical product CREON DR capsules. The award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,488.44 firm fixed-price delivery order contract is for the provision of 36,000 unit capsules of the product "CREON DR" with an ultimate completion date of March 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary...
This federal contract award, valued at $1,758.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract is for the delivery of 12,000 unit capsules of the drug CREON DR, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and provides a wide range of pharmaceutical...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,779.96 firm-fixed-price delivery order is for the supply of 24,000 unit capsules of the drug CREON DR. The award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FB93A
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,577.04 firm fixed-price contract is for the delivery of 24,000 unit capsules of the drug CREON DR. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award supports the DLA's mission to provide medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other essential medical supplies, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 5/16/25, 12:21 PM